{"id":"W4385295238","doi":"10.1097/mou.0000000000001114","title":"Poly-ADP ribose polymerase inhibitor and androgen receptor signaling inhibitor for all comers for first-line treatment of metastatic castration-resistant prostate cancer: is gene sequencing out?","year":2023,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Olaparib; Medicine; Enzalutamide; Prostate cancer; Oncology; PARP inhibitor; Clinical endpoint; Internal medicine; Clinical trial; Biomarker; Androgen receptor; Cancer; Cancer research; Polymerase; Genetics; Gene; Poly ADP ribose polymerase; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003757392,0.0006380297,0.002262344,0.0006502956,0.000132263,0.0000281129,0.0001130294,0.0002502249,0.00002930854],"category_scores_gemma":[0.00009688616,0.0004891219,0.0004799882,0.0003527546,0.000201021,0.00007173313,0.00005725443,0.0002354071,0.000005300916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008888092,"about_ca_system_score_gemma":0.001513027,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001287898,"about_ca_topic_score_gemma":0.00006243778,"domain_scores_codex":[0.9965368,0.0001608591,0.001406371,0.0008832053,0.0002798739,0.0007329147],"domain_scores_gemma":[0.9978452,0.0007109654,0.0006415742,0.0003156914,0.0002099634,0.0002766174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003891635,0.001001975,0.000217999,0.1053509,0.002643644,0.00002633863,0.002974331,0.00001476681,0.00075741,0.0000400637,0.002389415,0.8806915],"study_design_scores_gemma":[0.01223822,0.006482617,0.000003263144,0.01025873,0.002404734,0.00002858976,0.0001413057,0.0002818952,0.00281818,0.00008743384,0.9646672,0.0005878539],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001487684,0.9793956,0.00004968528,0.001039481,0.002819043,0.007742947,0.007423826,0.00004064499,0.000001057122],"genre_scores_gemma":[0.000252404,0.9867847,0.000351669,0.00002133287,0.00109157,0.006004184,0.005225659,0.0001239237,0.0001445867],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9622778,"threshold_uncertainty_score":0.999756,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2466058386296354,"score_gpt":0.457347030506748,"score_spread":0.2107411918771126,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}